DRGEM Corporation (KOSDAQ:263690)
4,905.00
-145.00 (-2.87%)
At close: Oct 23, 2026
DRGEM Revenue
DRGEM had revenue of 29.89B KRW in the quarter ending June 30, 2026, with 10.00% growth. This brings the company's total for the last twelve months to 109.45B, up 11.35% year-over-year. In the year 2025, DRGEM had annual revenue of 102.75B, down -1.21%. That makes DRGEM the 24,113th largest company in the world by revenue and 1,389th in South Korea.
Revenue (ttm)
109.45B
Revenue Growth
+11.35%
P/S Ratio
0.49
Revenue / Employee
414.59M
Employees
264
Market Cap
53.44B
Revenue by Geography
- Overseas 92.02B 89.6%
- South Korea 10.73B 10.4%
Fiscal year ended Dec 31, 2025 See the full DRGEM breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 102.75B | -1.26B | -1.21% |
| Dec 31, 2024 | 104.01B | -8.91B | -7.89% |
| Dec 31, 2023 | 112.92B | 2.75B | 2.50% |
| Dec 31, 2022 | 110.17B | 24.41B | 28.47% |
| Dec 31, 2021 | 85.75B | -20.85B | -19.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Genoray | 107.88B |
| CU Medical Systems | 62.40B |
| JPI Healthcare | 46.86B |
| Hironic | 37.10B |
| SELVAS Healthcare | 31.69B |
| Remed | 27.05B |
| Dynamic solution | 15.11B |
| QuantaMatrix | 3.15B |